Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 ...

Novo Nordisk (NVO) stock and Eli Lilly (LLY) stock are in focus as the FDA seeks to remove suicide-risk warnings related to their GLP-1 weight-loss drugs. Read more here.

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...

The Food and Drug Administration has upgraded a nationwide cheese recall that includes products sold at major Texas retailers ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical found that scrapings of ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...